Current Advances in Zika Vaccine Development

Current Advances in Zika Vaccine Development

Zika virus (ZIKV), an emerging arthropod-borne flavivirus, was first isolated in Uganda in 1947 from monkeys and first detected in humans in Nigeria in 1952; it has been associated with a dramatic burden worldwide. Since then, interventions to reduce the burden of ZIKV infection have been mainly res...

Full description

Bibliographic Details
Main Authors:	Yuchen Wang, Lin Ling, Zilei Zhang, Alejandro Marin-Lopez
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Vaccines
Subjects:	Zika virus Zika vaccines DNA vaccines mRNA vaccines live attenuated whole inactivated
Online Access:	https://www.mdpi.com/2076-393X/10/11/1816

Similar Items

An update on Zika vaccine developments
by: Anna Durbin, et al.
Published: (2017-08-01)

Nucleic Acid Vaccine Platform for DENGUE and ZIKA Flaviviruses
by: Jarin Taslem Mourosi, et al.
Published: (2022-05-01)

Rational Development of Live-Attenuated Zika Virus Vaccines
by: Awadalkareem Adam, et al.
Published: (2023-01-01)

Zika virus: Vaccine initiatives and obstacles
by: Reema Mukherjee, et al.
Published: (2017-01-01)

Pushing Forward With Zika Vaccines
by: Richard B. Kennedy
Published: (2016-11-01)

THE CURRENT APPROACHES TO ZIKA VIRUS VACCINATION
by: Can, et al.
Published: (2016-08-01)

Current trends in Zika vaccine development
by: Francisco A. Lagunas-Rangel, et al.
Published: (2017-07-01)

Zika vaccines and therapeutics: landscape analysis and challenges ahead
by: Wilder-Smith, Annelies, et al.
Published: (2018)

Development of Zika Virus DNA Vaccine Using Envelope Modified Baculoviral Gene Delivery System
by: Hanul Choi, et al.
Published: (2020-06-01)

Current Progress in the Development of Zika Virus Vaccines
by: Kehui Zhou, et al.
Published: (2021-09-01)

Zika virus—an update on the current efforts for vaccine development
by: Victória Alves Santos Lunardelli, et al.
Published: (2021-03-01)

Development of Zika Virus Vaccines
by: Huda Makhluf, et al.
Published: (2018-01-01)

Inactivation of Zika Virus by Photoactive Iodonaphthyl Azide Preserves Immunogenic Potential of the Virus
by: Amy L. Austin, et al.
Published: (2019-10-01)

Immunological Assays used to Support Efficacy of Zika Virus Vaccines
by: Kenneth H. Eckels, et al.
Published: (2019-06-01)

Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics
by: Monica A. McArthur
Published: (2017-06-01)

The latest advancements in Zika virus vaccine development
by: Lanying Du, et al.
Published: (2017-10-01)

Framing and visual type: Effect on future Zika vaccine uptake intent
by: Jeanine P.D. Guidry, et al.
Published: (2018-04-01)

Willingness to Participate and Associated Factors in a Zika Vaccine Trial in Indonesia: A Cross-Sectional Study
by: Harapan Harapan, et al.
Published: (2018-11-01)

Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells
by: Carla Bianca Luena Victorio, et al.
Published: (2024-02-01)

Using Next Generation Sequencing to Study the Genetic Diversity of Candidate Live Attenuated Zika Vaccines
by: Natalie D. Collins, et al.
Published: (2020-04-01)

Current Status of Zika Virus Vaccines: Successes and Challenges
by: Aryamav Pattnaik, et al.
Published: (2020-05-01)

mRNA Vaccines against Flaviviruses
by: Clayton J. Wollner, et al.
Published: (2021-02-01)

A Glimmer of Hope: Recent Updates and Future Challenges in Zika Vaccine Development
by: Priscila M. S. Castanha, et al.
Published: (2020-11-01)

Zika virus knowledge and vaccine acceptance among undergraduate students in Guayaquil, Ecuador
by: Madison Searles, et al.
Published: (2023-04-01)

Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
by: Majed Ghattas, et al.
Published: (2021-12-01)

Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice
by: Albert To, et al.
Published: (2018-02-01)

Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
by: Yu-Jing Fan, et al.
Published: (2021-09-01)

Zika vaccines and therapeutics: landscape analysis and challenges ahead
by: Annelies Wilder-Smith, et al.
Published: (2018-06-01)

Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
by: Qi Chen, et al.
Published: (2018-11-01)

COVID-19 Vaccines: Where Did We Stand at the End of 2023?
by: Kenneth Lundstrom
Published: (2024-01-01)

Fast Tracks and Roadblocks for Zika Vaccines
by: Khairunnisa Abdul Ghaffar, et al.
Published: (2018-11-01)

Zika Fever: Development of Diagnostics, Prevention and Treatment
by: E. I. Kazachinskaya, et al.
Published: (2019-07-01)

Zika vaccine pre-clinical and clinical data review with perspectives on the future development
by: Stephen J. Thomas, et al.
Published: (2020-10-01)

Cross-Protection Against Four Serotypes of Dengue Virus in Mice Conferred by a Zika DNA Vaccine
by: Ran Wang, et al.
Published: (2019-05-01)

Clinical Trials and Administration of Zika Virus Vaccine in Pregnant Women: Lessons (that Should Have Been) Learned from Excluding Immunization with the Ebola Vaccine during Pregnancy and Lactation
by: David A. Schwartz
Published: (2018-12-01)

In silico design of a Zika virus non-structural protein 5 aiming vaccine protection against zika and dengue in different human populations
by: Lorrany dos Santos Franco, et al.
Published: (2017-11-01)

Recent Advances in Zika Virus Vaccines
by: Himanshu Garg, et al.
Published: (2018-11-01)

A vaccine effective against Zika virus is theoretically possible but may not be delivered anytime soon
by: Taylor-Robinson AW
Published: (2016-07-01)

Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation
by: Eun Kim, et al.
Published: (2016-11-01)

Designing Multi‐Epitope Subunit Vaccine Candidate for Zika Virus Utilizing In silico Tools
by: Fatemeh Shams Moattar, et al.
Published: (2022-03-01)